- On May 4, 2015, PositiveID Corp was trading for $0.02 and has since increased 75%. PositiveID Corp's stock edged up 1.89% to close Tuesday's session at USD 0.04. The stock recorded a trading volume of 13.7 million shares, which was much above its 30-day daily average volume of 4.4 million shares. The company is trading close to its 50-day moving average of USD 0.03. Recently on October 21, 2015, PositiveID Corporation, a developer of biological detection and diagnostics solutions, announced that it has entered into an agreement to acquire the capital stock of Thermomedics, Inc., which manufactures and markets the FDA-cleared Caregiver(R) non-contact clinical-grade thermometer. The Company informed that the acquisition is expected to strengthen its FDA and manufacturing capabilities, and enhance distribution channels into synergistic federal and commercial healthcare customers. William J. Caragol, Chairman and CEO of PositiveID, commented, "We believe that once completed, the acquisition of Thermomedics will bring an exciting product and management team to our portfolio as we continue toward commercialization of Firefly Dx. Not only will Caregiver provide additional revenue for PositiveID, we believe it will also provide opportunities to fight against the spread of disease, while providing a pathway to customers and delivering proven manufacturing and FDA expertise."
